Sponsor:
Indiana University
Code:
NCT05386043
Conditions
Glioma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FET F-18
O-15 Radioisotope
CT scan
MRI with gadolinium-based contrast
Biopsy Collection
Brief summary:
Conditions
Glioma
Study ID
NCT05386043
Start date
Jul 18, 2023
Status verified date
Sep, 2025
Completion date
Jul 17, 2032
Anticipated
Primary completion date
Jul 17, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
20 participants
Anticipated
Arms
Baseline Imaging and Biopsy
Interventions
FET F-18
O-15 Radioisotope
CT scan
MRI with gadolinium-based contrast
Biopsy Collection
Primary outcome measure
Central contacts
Locations
Indiana University School of Medicine
Recruiting
Indianapolis, Indiana, United States, 46202
Contacts
Principal Investigator:
Jason Parker, PhD
Sponsor
Indiana University
Last update posted
Sep 15, 2025
Last verified
Sep, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Indiana University on 2025-09-15.